Article Information
History
- December 27, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Pui San Tan1,
- Ashley Kieran Clift1,2,
- Weiqi Liao1,
- Martina Patone1,
- Carol Coupland1,3,
- Rachael Bashford-Rogers4,
- Shivan Sivakumar5,6,7,
- David Clifton8,
- Stephen P Pereira9 and
- Julia Hippisley-Cox1,*
- 1Nuffield Department of Primary Care Health Sciences, University of Oxford
- 2Cancer Research UK Oxford Centre, Department of Oncology, University of Oxford
- 3Division of Primary Care, School of Medicine, University of Nottingham
- 4Wellcome Centre for Human Genomics, University of Oxford
- 5Department of Oncology, University of Oxford
- 6Kennedy Institute of Rheumatology, University of Oxford
- 7Department of Oncology, Oxford University Hospitals NHS Foundation Trusts
- 8Department of Engineering Science, University of Oxford
- 9UCL Institute for Liver and Digestive Health, University College London
- ↵*Corresponding author: Professor Julia Hippisley-Cox, Nuffield Department of Primary Care Health Sciences, University of Oxford Radcliffe Primary Care Building, Radcliffe Observatory Quarter, Woodstock Road, Oxford OX2 6GG, UK., julia.hippisley-cox{at}phc.ox.ac.uk
Posted December 27, 2021.
Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the development and validation of a clinical prediction model (QPancreasD)
